Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,413 | 132 | 62.4% |
| Travel and Lodging | $4,485 | 8 | 33.3% |
| Consulting Fee | $500.00 | 1 | 3.7% |
| Entertainment | $89.35 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $3,634 | 20 | $0 (2017) |
| Alcon Vision LLC | $3,130 | 23 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,568 | 19 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $1,522 | 18 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $598.35 | 2 | $0 (2019) |
| Allergan, Inc. | $352.32 | 17 | $0 (2022) |
| Amgen Inc. | $273.65 | 2 | $0 (2024) |
| ABBVIE INC. | $270.27 | 6 | $0 (2023) |
| CooperVision Inc. | $244.79 | 5 | $0 (2024) |
| LKC Technologies, Inc. | $237.51 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,432 | 17 | Bausch & Lomb Americas Inc. ($477.70) |
| 2023 | $3,364 | 27 | Alcon Vision LLC ($2,299) |
| 2022 | $1,111 | 19 | Bausch & Lomb Americas Inc. ($594.52) |
| 2021 | $996.53 | 14 | Bausch & Lomb, a division of Bausch Health US, LLC ($477.15) |
| 2020 | $186.57 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($151.29) |
| 2019 | $1,346 | 12 | Aerie Pharmaceuticals, Inc. ($598.35) |
| 2018 | $958.78 | 19 | Bausch & Lomb, a division of Bausch Health US, LLC ($547.20) |
| 2017 | $4,091 | 30 | Valeant Pharmaceuticals North America LLC ($3,634) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $126.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $67.91 | General |
| Category: Devices | ||||||
| 10/30/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $139.35 | General |
| 10/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $86.83 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | LKC Technologies, Inc. | — | Food and Beverage | In-kind items and services | $116.46 | General |
| 08/20/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $146.78 | General |
| 06/18/2024 | Glaukos Corporation | iStent Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $142.34 | General |
| Category: Glaucoma | ||||||
| 06/10/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Ophthalmology | ||||||
| 03/12/2024 | Bausch & Lomb Americas Inc. | INFUSE MULTIFOCAL (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Ophthalmology | ||||||
| 02/22/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: Ophthalmology | ||||||
| 02/09/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $85.87 | General |
| Category: Ophthalmology | ||||||
| 02/09/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Ophthalmology | ||||||
| 01/19/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Ophthalmology | ||||||
| 12/12/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Ophthalmology | ||||||
| 11/21/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Ophthalmology | ||||||
| 11/21/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Ophthalmology | ||||||
| 11/15/2023 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $67.52 | General |
| Category: Devices | ||||||
| 11/12/2023 | Alcon Vision LLC | — | Travel and Lodging | In-kind items and services | $1,041.86 | General |
| Category: Ophthalmology | ||||||
| 11/12/2023 | Alcon Vision LLC | — | Travel and Lodging | In-kind items and services | $507.14 | General |
| Category: Ophthalmology | ||||||
| 11/12/2023 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $332.03 | General |
| Category: Ophthalmology | ||||||
| 11/12/2023 | Alcon Vision LLC | — | Travel and Lodging | In-kind items and services | $197.83 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 455 | 522 | $83,582 | $24,902 |
| 2022 | 5 | 453 | 527 | $84,828 | $25,358 |
| 2021 | 5 | 441 | 520 | $83,474 | $25,416 |
| 2020 | 8 | 434 | 498 | $75,713 | $22,508 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 208 | $26,135 | $12,147 | 46.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 105 | 108 | $16,737 | $4,762 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 46 | $7,707 | $3,924 | 50.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 120 | 140 | $28,878 | $3,464 | 12.0% |
| 92134 | Imaging of retina | Office | 2023 | 19 | 20 | $4,126 | $604.74 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 202 | $25,376 | $11,925 | 47.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 108 | 109 | $16,878 | $4,824 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 51 | $8,545 | $4,395 | 51.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 113 | 140 | $28,872 | $3,409 | 11.8% |
| 92134 | Imaging of retina | Office | 2022 | 23 | 25 | $5,157 | $804.20 | 15.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 152 | 188 | $23,202 | $11,205 | 48.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 61 | $10,115 | $5,341 | 52.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 101 | 105 | $16,122 | $4,588 | 28.5% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 112 | 143 | $29,320 | $3,642 | 12.4% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 19 | 23 | $4,715 | $640.02 | 13.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 76 | $11,940 | $5,879 | 49.2% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 92 | 105 | $15,392 | $4,800 | 31.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 95 | 117 | $23,277 | $2,961 | 12.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 86 | 95 | $7,460 | $2,749 | 36.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 54 | $6,220 | $2,634 | 42.4% |
| 66984 | Removal of cataract with insertion of lens | Office | 2020 | 11 | 19 | $5,372 | $1,760 | 32.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 12 | 12 | $2,073 | $1,154 | 55.7% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 17 | 20 | $3,979 | $571.47 | 14.4% |
About Dr. Cherilyn Lai, O.D
Dr. Cherilyn Lai, O.D is a Optometrist healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811941743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cherilyn Lai, O.D has received a total of $13,487 in payments from pharmaceutical and medical device companies, with $1,432 received in 2024. These payments were reported across 143 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($8,413).
As a Medicare-enrolled provider, Lai has provided services to 1,783 Medicare beneficiaries, totaling 2,067 services with total Medicare billing of $98,184. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Honolulu, HI
- Active Since 05/22/2006
- Last Updated 12/01/2012
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1811941743
Products in Payments
- BIOTRUE ONE DAY (Device) $2,205
- ULTRA (Device) $1,603
- INFUSE (Device) $1,271
- DAILIES (Device) $629.81
- Rocklatan (Drug) $598.35
- TOTAL30 (Device) $546.44
- BTOD (Device) $413.66
- VUITY (Drug) $277.88
- VYZULTA (Drug) $277.57
- BIOTRUE (Device) $257.03
- RESTASIS (Drug) $192.12
- TEPEZZA (Drug) $161.28
- CIRRUS HD-OCT (Device) $154.75
- INFUSE MULTIFOCAL (Device) $150.00
- ZEN LENS (Device) $150.00
- ULTRA MULTIFOCAL TORIC (Device) $147.57
- iStent Trabecular Micro-Bypass System Model iS3 (Device) $142.34
- MyDay Contact Lens (Device) $135.43
- XIIDRA (Drug) $135.39
- TEPEZZA (Biological) $126.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Honolulu
Dr. Randall Sakamoto, O.d., Ph.d, O.D., PH.D
Optometrist — Payments: $57,938
Dr. Kensey Inouye, Od, OD
Optometrist — Payments: $14,402
Dr. Peter Shoji, O.d, O.D
Optometrist — Payments: $13,562
Dr. Derrick Abe, O.d, O.D
Optometrist — Payments: $12,539
Dr. Chris Yamamoto, O.d, O.D
Optometrist — Payments: $12,031
Dr. Keith Kawamura, Od, OD
Optometrist — Payments: $11,714